Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best CJC-1295 No DAC & Ipamorelin Dosage Fat Loss 2026: Research Protocol Comparison

Conservative Research Protocol 50mcg 200mcg 3x weekly (MWF) 8–12% visceral fat reduction in caloric deficit Lowest effective dose. Ideal for first-time researchers or those concerned about insulin sensitivity Standard Research Protocol 100mcg 12–18% visceral f

This comparison does not assign a generated winner or score.

  • Conservative Research Protocol
  • 50mcg
  • 200mcg
  • 3x weekly (MWF)
  • 8–12% visceral fat reduction in caloric deficit
  • Lowest effective dose. Ideal for first-time researchers or those concerned about insulin sensitivity
  • Standard Research Protocol
  • 100mcg
  • 12–18% visceral fat reduction, improved fasted fat oxidation
  • Most commonly cited in metabolic studies. Balances efficacy and peptide cost
  • Aggressive Research Protocol
  • 300mcg
  • 5x weekly or daily (first 4 weeks)
  • 15–22% visceral fat reduction, significant subcutaneous changes
  • Higher peptide consumption; some researchers report mild water retention or carpal tunnel-like symptoms
  • Extended Half-Life (DAC) Protocol
  • 100mcg CJC + DAC
  • 2x weekly
  • 6–10% visceral fat reduction. Lower lipolytic response
  • Convenience-focused but sacrifices pulsatile GH pattern; not recommended for fat loss-specific goals
More references

Related material